Sanders Morris Harris LLC Reata Pharmaceuticals Inc Transaction History

Sanders Morris Harris LLC

  • $585 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 26, 2021
SELL
$102.03 - $184.62 $1.39 Million - $2.51 Million
-13,595 Closed
0 $0
Q3 2020

Oct 16, 2020
BUY
$93.53 - $163.34 $997,965 - $1.74 Million
10,670 Added 364.79%
13,595 $1.5 Million
Q2 2020

Jul 09, 2020
BUY
$126.3 - $176.56 $369,427 - $516,438
2,925 New
2,925 $450,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Sanders Morris Harris LLC Portfolio

Follow Sanders Morris Harris LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanders Morris Harris LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email